{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T12:00:10Z","timestamp":1776168010144,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["1004890"],"award-info":[{"award-number":["1004890"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016285","name":"TDR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016285","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jiph.2026.103214","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T16:59:23Z","timestamp":1774630763000},"page":"103214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic performance of molecular and serological markers for hepatitis E virus and Toxoplasma gondii coinfection across gestation in HIV-positive pregnant women"],"prefix":"10.1016","volume":"19","author":[{"given":"Peter Mac","family":"Asaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorcas","family":"Bulus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Makpo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Yako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philomena E.","family":"Airiohuodion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jiph.2026.103214_bib1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nri.2017.64","article-title":"The unique immunological and microbial aspects of pregnancy","volume":"17","author":"Mor","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jiph.2026.103214_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.575197","article-title":"Maternal immunological adaptation during normal pregnancy","volume":"11","author":"Abu-Raya","year":"2020","journal-title":"Front Immunol"},{"issue":"37","key":"10.1016\/j.jiph.2026.103214_bib3","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.3748\/wjg.v26.i37.5543","article-title":"Hepatitis E virus: epidemiology, diagnosis, clinical manifestations, and treatment","volume":"26","author":"Aslan","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jiph.2026.103214_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/pathogens8010024","article-title":"Maternal and congenital toxoplasmosis: diagnosis and treatment recommendations","volume":"8","author":"Peyron","year":"2019","journal-title":"Pathogens"},{"key":"10.1016\/j.jiph.2026.103214_bib5","article-title":"Prevalence and determinants of HIV among reproductive-age women (15\u201349 years) in Africa from 2010 to 2019: a multilevel analysis","volume":"12","author":"Gedefie","year":"2024","journal-title":"Front Public Health"},{"key":"10.1016\/j.jiph.2026.103214_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fgwh.2022.820759","article-title":"Preterm birth in women with HIV: the role of the placenta","volume":"3","author":"Ikumi","year":"2022","journal-title":"Front Glob Women\u2019s Health"},{"issue":"31","key":"10.1016\/j.jiph.2026.103214_bib7","doi-asserted-by":"crossref","first-page":"7030","DOI":"10.3748\/wjg.v22.i31.7030","article-title":"Hepatitis E: discovery, global impact, control and cure","volume":"22","author":"Khuroo","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jiph.2026.103214_bib8","unstructured":"Centers for Disease Control and Prevention. Hepatitis E. CDC Yellow Book 2024. Atlanta: CDC; 2024 Available from: \u3008https:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2024\/infections-diseases\/hepatitis-e\u3009 [Accessed 15 March 2026]."},{"key":"10.1016\/j.jiph.2026.103214_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2022.105353","article-title":"Prevalence of hepatitis E virus and its association with adverse pregnancy outcomes in pregnant women in China","volume":"158","author":"Qian","year":"2023","journal-title":"J Clin Virol"},{"issue":"9","key":"10.1016\/j.jiph.2026.103214_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00505-20","article-title":"Role of Toxoplasma gondii IgG avidity testing in discriminating between acute and chronic toxoplasmosis in pregnancy","volume":"58","author":"Teimouri","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jiph.2026.103214_bib11","doi-asserted-by":"crossref","DOI":"10.1590\/s1678-9946202466043","article-title":"Evaluation of different cut-off points for IgG avidity and IgM in the diagnosis of acute toxoplasmosis in pregnant women","volume":"66","author":"Laguardia","year":"2024","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.jiph.2026.103214_bib12","unstructured":"UNAIDS. Global HIV & AIDS statistics \u2013 Fact sheet 2024. Geneva: Joint United Nations Programme on HIV\/AIDS; 2024 Available from: \u3008https:\/\/www.unaids.org\/en\/resources\/fact-sheet\u3009 [Accessed 15 March 2026]."},{"key":"10.1016\/j.jiph.2026.103214_bib13","unstructured":"National Agency for the Control of AIDS. Nigeria HIV\/AIDS indicator and impact survey (NAIIS) 2018: technical report. Abuja: Federal Republic of Nigeria; 2019 Available from: \u3008https:\/\/naca.gov.ng\/naiis-report\/\u3009 [Accessed 15 March 2026]."},{"key":"10.1016\/j.jiph.2026.103214_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fgwh.2023.1190170","article-title":"Triple sexually transmitted infections among pregnant women in the context of elimination of mother to child transmission in Southern Ethiopia","volume":"4","author":"Israel","year":"2023","journal-title":"Front Glob Women\u2019s Health"},{"issue":"3","key":"10.1016\/j.jiph.2026.103214_bib15","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/infdis\/jis688","article-title":"Test performance characteristics of anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates","volume":"207","author":"Wenzel","year":"2013","journal-title":"J Infect Dis"},{"issue":"12\u201313","key":"10.1016\/j.jiph.2026.103214_bib16","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0020-7519(00)00124-7","article-title":"Toxoplasma gondii: from animals to humans","volume":"30","author":"Tenter","year":"2000","journal-title":"Int J Parasitol"},{"issue":"4","key":"10.1016\/j.jiph.2026.103214_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2023.115901","article-title":"Evaluation of Toxoplasma gondii IgG avidity assays through a comparison of IgM serostatus","volume":"105","author":"Ikuta","year":"2023","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.jiph.2026.103214_bib18","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jiac.2023.11.019","article-title":"Toxoplasma gondii IgG avidity for the diagnosis of primary infection in pregnant women: comparison between chemiluminescent microparticle immunoassay and enzyme-linked immunosorbent assay","volume":"30","author":"Ota","year":"2024","journal-title":"J Infect Chemother"},{"issue":"7","key":"10.1016\/j.jiph.2026.103214_bib19","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified Poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jiph.2026.103214_bib20","unstructured":"R. Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2023."},{"issue":"8","key":"10.1016\/j.jiph.2026.103214_bib21","first-page":"739","article-title":"Systematic evaluation of guidelines for the diagnosis and treatment of hepatitis E virus infection","volume":"12","author":"Tang","year":"2024","journal-title":"J Clin Transl Hepatol"},{"issue":"3","key":"10.1016\/j.jiph.2026.103214_bib22","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jinf.2016.12.004","article-title":"HEV infection in French HIV-infected patients","volume":"74","author":"Abravanel","year":"2017","journal-title":"J Infect"},{"issue":"9","key":"10.1016\/j.jiph.2026.103214_bib23","first-page":"993","article-title":"IgG avidity test as a tool for discrimination between recent and distant Toxoplasma gondii infection\u2014current status of studies and main limitations","volume":"11","author":"Holec-G\u0105sior","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.jiph.2026.103214_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/1514178","article-title":"Systematic review and meta-analysis of congenital toxoplasmosis diagnosis: advances and challenges","volume":"2024","author":"Franco","year":"2024","journal-title":"J Trop Med"},{"key":"10.1016\/j.jiph.2026.103214_bib25","unstructured":"World Health Organisation. WHO recommendations on antenatal care for a positive pregnancy experience. Geneva: World Health Organisation; 2016 Available from: \u3008https:\/\/www.who.int\/publications\/i\/item\/9789241549912\u3009 [Accessed 15 March 2026]."},{"issue":"9940","key":"10.1016\/j.jiph.2026.103214_bib26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0140-6736(14)60792-3","article-title":"Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost?","volume":"384","author":"Bhutta","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jiph.2026.103214_bib27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12985-020-01343-9","article-title":"Hepatitis E virus infection during pregnancy","volume":"17","author":"Wu","year":"2020","journal-title":"Virol J"},{"issue":"2","key":"10.1016\/j.jiph.2026.103214_bib28","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-3860","article-title":"Committee on Infectious Diseases. Diagnosis, treatment, and prevention of congenital toxoplasmosis in the United States","volume":"139","author":"Maldonado","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.jiph.2026.103214_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.888218","article-title":"Seroprevalence and burden of hepatitis E viral infection among pregnant women in central Nigeria attending antenatal clinic at a Federal Medical Centre in Central Nigeria","volume":"9","author":"Ehi Airiohuodion","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.jiph.2026.103214_bib30","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.csbj.2021.03.038","article-title":"Structural and molecular biology of hepatitis E virus","volume":"19","author":"Wang","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"issue":"1","key":"10.1016\/j.jiph.2026.103214_bib31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jviromet.2005.07.004","article-title":"A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus","volume":"131","author":"Jothikumar","year":"2006","journal-title":"J Virol Methods"},{"issue":"1","key":"10.1016\/j.jiph.2026.103214_bib32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12985-018-1082-8","article-title":"A new hepatitis E virus genotype 2 strain identified from an outbreak in Nigeria, 2017","volume":"15","author":"Wang","year":"2018","journal-title":"Virol J"},{"issue":"1","key":"10.1016\/j.jiph.2026.103214_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/MRA.01378-18","article-title":"Complete genome sequence of a hepatitis E virus genotype 1e strain from an outbreak in Nigeria, 2017","volume":"8","author":"Akanbi","year":"2019","journal-title":"Microbiol Resour Announc"},{"issue":"5","key":"10.1016\/j.jiph.2026.103214_bib34","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3390\/pathogens9050392","article-title":"Hepatitis E virus seroprevalence and associated risk factors in apparently healthy individuals from Osun State, Nigeria","volume":"9","author":"Osundare","year":"2020","journal-title":"Pathogens"},{"issue":"6","key":"10.1016\/j.jiph.2026.103214_bib35","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3390\/diagnostics14060602","article-title":"Assessment of the diagnostic performance of fully automated hepatitis E virus (HEV) antibody tests","volume":"14","author":"Eichhorn","year":"2024","journal-title":"Diagnostics"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034126000869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034126000869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T11:14:26Z","timestamp":1776165266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034126000869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1876034126000869"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2026.103214","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic performance of molecular and serological markers for hepatitis E virus and Toxoplasma gondii coinfection across gestation in HIV-positive pregnant women","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2026.103214","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}],"article-number":"103214"}}